5//SEC Filing
Feeney John Joseph 5
Accession 0001209191-12-009594
CIK 0001347178other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:37 PM ET
Size
8.9 KB
Accession
0001209191-12-009594
Insider Transaction Report
Form 5
Feeney John Joseph
Acting Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2011-02-18+7,500→ 7,500 total - Sale
Common Stock
2011-02-18$7.25/sh−2,985$21,641→ 4,515 total - Exercise/Conversion
Restricted Stock Unit
2011-02-18−7,500→ 22,500 total→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
- [F2]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2011. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
- [F3]N/A
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001454240
Filing Metadata
- Form type
- 5
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:37 PM ET
- Size
- 8.9 KB